Difference between revisions of "Foregen"

From IntactiWiki
Jump to navigation Jump to search
m (adjusted REFjournal)
(General revision and update.)
Line 1: Line 1:
 
[[Image:Foregen logo.png|right]]
 
[[Image:Foregen logo.png|right]]
'''Foregen'''’s goal is to heal the physical detriment that is inherent to [[circumcision]].
 
  
 +
'''Foregen''' is a registered Italian charity. Foregen was founded by Sig. [[Vincenzo Aiello]] of Italy to promote and arrange a clinical trial that would use regenerative techniques to regrow the tissue removed at circumcision. Foregen's goal is to heal the physical loss of functional tissue that is inherent to [[circumcision]]. Foregen's principal office is at Via Campi Flegrei 59, 00141 Rome, Italy.
 +
==History==
 +
After dismissing many unsatisfactory proposals from research institutions, Foregen decided to conduct its own research and clinical trials. Foregen has applied regenerative techniques to animal foreskins and will continue research on adult human foreskins.
 +
 +
Foregen announced in 2018 that it had completed a decellularized extracellular matrix–based biomaterial scaffold, which is to be used in foreskin regeneration.<ref>{{REFjournal
 +
|last=Purpura
 +
|first=Valeria
 +
|init=V
 +
|author-link=
 +
|last2=Bondioli
 +
|first2=Elena
 +
|init2=E
 +
|author2-link=
 +
|last3=Cunningham
 +
|first3=Eric J.
 +
|init3=EC
 +
|author3-link=
 +
|etal=yes
 +
|title=The development of a decellularized extracellular matrix–based biomaterial scaffold derived from human foreskin for the purpose of foreskin reconstruction in circumcised males
 +
|journal=J Tissue Eng
 +
|location=
 +
|date=2018-12-22
 +
|volume=
 +
|issue=
 +
|pages=
 +
|url=https://journals.sagepub.com/doi/full/10.1177/2041731418812613
 +
|quote=
 +
|pubmedID=30622692
 +
|pubmedCID=6304708
 +
|DOI=10.1177/2041731418812613
 +
|accessdate=2020-02-09
 +
}}</ref>
 +
 +
Foregen announced in December 2021 that it is hoped that clinical trials would commence in April 2023.<ref>{{REFweb
 +
|url=https://www.foregen.org/clinical-trials
 +
|title=Human Clinical Trials Application Form
 +
|last=
 +
|first=
 +
|date=2021-12
 +
|accessdate=2021-12-20
 +
}}</ref>
 +
 +
==Regenerative medicine==
 
Regenerative medical techniques now offer a greater possibility than ever to regrow human tissue, especially dermal tissue, lost in prior trauma. Regenerative medicine has been used to recreate vaginas of women with some congenital conditions<ref>{{REFnews
 
Regenerative medical techniques now offer a greater possibility than ever to regrow human tissue, especially dermal tissue, lost in prior trauma. Regenerative medicine has been used to recreate vaginas of women with some congenital conditions<ref>{{REFnews
 
  |last=Richardson
 
  |last=Richardson
Line 67: Line 109:
 
  |date=2014-04-22
 
  |date=2014-04-22
 
  |accessdate=2015-07-15
 
  |accessdate=2015-07-15
}}</ref>. However, regenerative medicine has not yet been applied to those who have been circumcised and no longer wish to be.
+
}}</ref>. However, regenerative medicine has not yet been applied to those who have been circumcised, but no longer wish to be.
 
 
==History==
 
Foregen was founded by Sig. [[Vincenzo Aiello]] of Italy to promote and arrange a clinical trial that would use regenerative techniques to regrow the tissue removed at circumcision. After dismissing many unsatisfactory proposals from research institutions, Foregen decided to conduct its own research and clinical trials. Foregen has applied regenerative techniques to animal foreskins and will continue research on adult human foreskins.
 
  
 
==Goals==
 
==Goals==
Line 96: Line 135:
 
==Progress reports==
 
==Progress reports==
  
Foregen announced in 2018 that it had completed a decellularized extracellular matrix–based biomaterial scaffold, which is to be used in foreskin regeneration.<ref>{{REFjournal
+
 
|last=Purpura
 
|first=Valeria
 
|init=V
 
|author-link=
 
|last2=Bondioli
 
|first2=Elena
 
|init2=E
 
|author2-link=
 
|last3=Cunningham
 
|first3=Eric J.
 
|init3=EC
 
|author3-link=
 
|etal=yes
 
|title=The development of a decellularized extracellular matrix–based biomaterial scaffold derived from human foreskin for the purpose of foreskin reconstruction in circumcised males
 
|journal=J Tissue Eng
 
|location=
 
|date=2018-12-22
 
|volume=
 
|issue=
 
|pages=
 
|url=https://journals.sagepub.com/doi/full/10.1177/2041731418812613
 
|quote=
 
|pubmedID=30622692
 
|pubmedCID=6304708
 
|DOI=10.1177/2041731418812613
 
|accessdate=2020-02-09
 
}}</ref>
 
 
== Social media ==
 
== Social media ==
 
* [https://www.youtube.com/channel/UCUPHstb4Zzc-e1lbJVrT5HA Youtube Channel]
 
* [https://www.youtube.com/channel/UCUPHstb4Zzc-e1lbJVrT5HA Youtube Channel]

Revision as of 11:51, 20 December 2021

Foregen logo.png

Foregen is a registered Italian charity. Foregen was founded by Sig. Vincenzo Aiello of Italy to promote and arrange a clinical trial that would use regenerative techniques to regrow the tissue removed at circumcision. Foregen's goal is to heal the physical loss of functional tissue that is inherent to circumcision. Foregen's principal office is at Via Campi Flegrei 59, 00141 Rome, Italy.

History

After dismissing many unsatisfactory proposals from research institutions, Foregen decided to conduct its own research and clinical trials. Foregen has applied regenerative techniques to animal foreskins and will continue research on adult human foreskins.

Foregen announced in 2018 that it had completed a decellularized extracellular matrix–based biomaterial scaffold, which is to be used in foreskin regeneration.[1]

Foregen announced in December 2021 that it is hoped that clinical trials would commence in April 2023.[2]

Regenerative medicine

Regenerative medical techniques now offer a greater possibility than ever to regrow human tissue, especially dermal tissue, lost in prior trauma. Regenerative medicine has been used to recreate vaginas of women with some congenital conditions[3]. Experiments have been performed to regenerate the penis of rabbits.[4] [5][6] Also progress has been made in penile transplants[7] [8] and phalloplasties[9]. However, regenerative medicine has not yet been applied to those who have been circumcised, but no longer wish to be.

Goals

Foregen’s tasks are:

  • To experiment with animal tissue to obtain a viable method of foreskin regeneration
  • To apply the experience from animal experiments to regenerate human foreskins
  • To advance onto clinical trials once Foregen proves that regenerating human foreskin is possible

Foregen is a charity

Foregen™ was created in 2010 thanks to donor funds. Foregen operates in the United States and Europe. Its head office is in Rome, Italy, where it is a registered charity (Reg. No. 6482, Serie 1T, 2010). See original founding documents here. Foregen is also tax-exempt under section 501(c)(3) of the Internal Revenue Code and is headed by a board of charitable directors with participants and donors across both continents and beyond.

For more information on the science behind Foregen, read: The science of regeneration

Video

Message from Foregen's president, Vincenzo Aiello.




Progress reports

Social media

Foregen in the media

See also

External links

References

  1. REFjournal Purpura V, Bondioli E, Cunningham EC, et al. The development of a decellularized extracellular matrix–based biomaterial scaffold derived from human foreskin for the purpose of foreskin reconstruction in circumcised males. J Tissue Eng. 22 December 2018; PMID. PMC. DOI. Retrieved 9 February 2020.
  2. REFweb (December 2021). Human Clinical Trials Application Form. Retrieved 20 December 2021.
  3. REFnews Richardson, Karen (10 April 2014)."Laboratory-Grown Vaginas Implanted in Patients, Scientists Report", Wake Forest Baptist Medical Center. Retrieved 15 July 2015.
  4. REFnews Geggel, Laura (9 October 2014)."Scientists developing lab-grown penis for transplant", LiveScience, CBS News. Retrieved 15 July 2015.
  5. REFnews "Engineered Penile Erectile Tissue", Wake Forest School of Medicine. Retrieved 15 July 2015.
  6. REFnews Mohammadi, Dara (4 October 2014)."The lab-grown penis: approaching a medical milestone", The Guardian. Retrieved 15 July 2015.
  7. REFnews Smith, David (13 March 2015)."Man gets world's first successful penis transplant after botched circumcision", The Guardian. Retrieved 15 July 2015.
  8. REFnews Feltman, Rachel (12 June 2015)."Man who had world's first penis transplant to become a father", The Independent. Retrieved 15 July 2015.
  9. REFnews Ho, Vivian (22 April 2014)."Man may be 1st to father child with reconstructed penis", SFGate. Retrieved 15 July 2015.